Change in Cognitive Function After Hospitalization
Despite increasing evidence for a strong association between cardiovascular disease and impaired cognition, 7, 11 change in cognitive function during the transitional period after hospitalization for acute coronary syndrome (ACS) has not been described. In addition to understanding the proportion of patients whose cognitive function fluctuates after discharge, identifying factors associated with whether a patient's cognitive function may change could help in designing transitional care plans, aligning services with patient profiles, and informing content and timing of follow-up appointments. We hypothesized that person-level variables such as low educational level, low health numeracy, depressive symptoms, or living alone might be associated with cognitive impairment during hospitalization and lower likelihood of recovery. Thus, we examined change in cognitive function from ACS hospitalization to 1 month post-discharge and the clinical, demographic, and psychosocial factors associated with different trajectories of change. One month post-discharge was chosen as our first follow-up time point because it corresponds with a critical period for hospital readmission.
Methods
Data are drawn from TRACE-CORE (Transition, Risks, and Actions in Coronary Events-Center for Outcomes Research and Education), which is a large longitudinal observational study of ACS patients from 6 hospitals in Massachusetts and Georgia. Details of the study have been described elsewhere. 12 In brief, potentially eligible patients were identified by daily screening of ACS-related ICD-9 codes (410-412) in computerized hospital, cardiac catheterization laboratory, and emergency department records by trained reviewers from April 2011 to May 2013, approached in the hospital and further screened for eligibility. Eligibility criteria included a diagnosis of ACS consistent with the American College of Cardiology and American Heart Association criteria, 13, 14 age 21 years or older, and ability to communicate in English or Spanish. Participants were excluded if they developed ACS secondary to another acute condition (eg, surgery), screened positive for delirium by the Confusion Assessment Method, 15 had documented dementia, were pregnant, imprisoned, expected to move out of the area within 18 months, or were admitted for palliative care only. Informed consent was obtained in writing from all participants, and the study was approved by institutional review boards at all study sites.
Information about patient's demographic characteristics, comorbidities, lifestyle changes, cognitive status, psychosocial measures, and experience of care during their hospitalization was collected by trained study staff via an in-person structured computer-assisted interview during hospitalization (baseline) and via telephone at 1 month after hospital discharge. Baseline assessments were conducted within a day of admission, and 1-month follow-up interviews were administered between day 24 and 35 post-discharge. Clinical characteristics and laboratory values were obtained via review of medical records for the index hospitalization.
Assessment of Cognitive Status
Patients' cognitive status was assessed during hospitalization (as part of the baseline in-person interview) and at 1 month post-discharge (as part of the follow-up telephone interview) using the Telephone Interview of Cognitive Status (TICS), a validated 11-item global cognitive screening instrument that can be administered in-person or over the phone. 16 The TICS is similar to the Mini-Mental State Examination in discriminating cognitive impairment from normal cognition 17 and has been used in other studies of patients with cardiovascular disease. 18 Cognitive status at both time points (in-hospital baseline and 1 month post-discharge) was dichotomized into nonimpaired and impaired using a cutoff score of ≤28 (range: 0-41, higher score indicates better cognition), consistent with previous epidemiological studies.
17,19

Definition of Change in Cognitive Status
For our main analysis, change in cognitive status was defined based on the cut point for impairment of ≤28 and we created a 4-category variable of change groups. Participants were classified as follows: consistently nonimpaired (nonimpaired at baseline and 1 month), transiently impaired (impaired at baseline and nonimpaired at 1 month), consistently impaired (impaired at both baseline and 1 month), or newly impaired (nonimpaired at baseline and impaired at 1 month).
In a sensitivity analysis, we also examined an alternative definition of change defined as an absolute change of ≥4 points from hospitalization to 1 month. Four-point change was selected because practice/retest effects on tests of global cognitive function are 0.3 to 0.4 SDs 20 (corresponding to a 1.16-1.55 point change in the current TRACE-CORE sample); thus, a 4-point change represents improvement of ≈3× that expected by practice alone.
Other Study Variables
All other study variables were assessed as part of the baseline, in-hospital interview, or as part of the baseline medical record abstraction, which was conducted ≈4 weeks after discharge to capture clinical variables during the index hospitalization. Participants self-reported demographic data including race/ethnicity, education, and living status (with spouse, alone, or with others) and health-related quality of life was assessed using the Short Form-36 Survey. 21 Participants were asked "How confident are you in filling out medical forms by yourself?" Responses of not at all confident, a little confident, and somewhat confident indicated impaired health literacy; responses of quite a bit confident and extremely confident indicated adequate health literacy. 22 Participants were asked "which of the following numbers represents the biggest risk of getting a disease?", first with response options of 1 in 100, 1 in 1000, and 1 in 10 and then again with response options of 1%, 10%, and 5%. Participants were categorized as having impaired health numeracy if they did not answer both questions correctly. 23 Depressive and anxiety symptoms were assessed with the 9-item Patient Health Questionnaire (range: 0-27) 24 and 7-item Generalized Anxiety Disorder scale (range: 0-21), 25 using a score of ≥10 on both scales to signify high depressive or anxiety symptoms. 25 Perceived stress and social support were assessed with the 4-item Perceived Stress Scale and the Medical Outcomes Study Social Support Scale (range: 5-25), 26 with participants scoring ≤12 having low social support. Age, sex, comorbid conditions (eg, atrial fibrillation, stroke), other clinical characteristics, and laboratory values were abstracted from the medical record. ACS severity was calculated using the Global Registry of Acute Coronary Events (GRACE) 6-month mortality risk score. 27, 28 The GRACE risk score includes the following components: age, heart rate, systolic blood pressure,
WHAT IS KNOWN
• Acute illness often results in cognitive impairment.
• This impairment is temporary or transient in some patients.
WHAT THE STUDY ADDS
• During hospitalization, cognitive impairment is transiently impaired in ≈10% of acute coronary syndrome survivors and new impairments developed in nearly 5% in the month after discharge.
• Cognitive status fluctuates during the transition from hospital to home and serial assessments before and after discharge are important.
creatinine, troponin I, ST depression on ECG, history of myocardial infarction, history of congestive heart failure, and percutaneous coronary intervention during hospitalization.
Statistical Analysis
We estimated odds ratios (ORs) and 95% confidence intervals (CIs) for transient impairment, consistent impairment, and new impairment in relation to the common reference group of consistent nonimpairment using multinomial logistic regression models. In multinomial logistic regression, the outcome is 1 of 3 or more categories, and models are simultaneously fit using maximum likelihood to estimate ORs for each group compared with a common reference group. 29 We included factors in adjusted regression models if they differed significantly by categories of cognitive change in univariate analyses. The GRACE risk score was included in the adjusted models as a surrogate for severity of ACS and represented several clinical characteristics and laboratory values, including age and history of myocardial infarction and cognitive heart failure, which were not included in the model separately because they were included in the GRACE score. In sensitivity analyses, we used an absolute change of 4 points to examine improvement, decline, and stability of cognitive performance, modeled using multinomial logistic regression as described above. In secondary analyses, we restricted the sample to only those who were impaired in the hospital and examined characteristics associated with recovery of cognitive function. All analyses were performed using SAS version 9.2 (SAS Institute Inc, Cary, NC).
Missing Data
Because there was significant loss to follow-up (below), we reanalyzed our data with inverse probability weighting, using the probability that an originally hospitalized TRACE-CORE participant was interviewed at 1 month and therefore included in our study. We also reanalyzed our data in 5 multiply imputed data sets.
Results
Study Sample
TRACE-CORE included 2191 patients enrolled in hospital and 19 died before the 1-month follow-up interview resulting in 2172 patients eligible for follow-up. Of these, 1529 were interviewed at 1 month and had data on cognitive function at both time points. We further excluded 8 patients with hospital stays longer than 30 days for a final analytic sample of 1521 ( Figure) . Compared with those included in our analytic sample (n=1521), those excluded (n=651) were younger (60.1 versus 61.9 years), less likely to be non-Hispanic white (74% versus 84%), more likely to have high depressive symptoms (30% versus 19%), and had lower in-hospital mean TICS scores (30.3 versus 32.1; all P<0.05). GRACE risk scores did not differ in the 2 groups (95.6 versus 95.5).
Patients in the analytic sample had a mean age of 62 years (SD=11.1), had a mean 6-month mortality GRACE risk score of 95.5 (SD=27.3), and were predominantly male (67%) and non-Hispanic white (84%).
Change in Cognitive Function in the Month After Discharge
Sixteen percent (n=237) of participants were cognitively impaired during hospitalization, and 11% (n=174) were impaired 1 month after discharge. Overall, 80% of the sample was consistently nonimpaired, 9% transiently impaired, 7% consistently impaired, and 4% newly impaired. Among those who were transiently impaired (n=130), 3% (n=4) improved 1 point, 6% (n=8) improved 2 points, and 9% (n=12) improved 3 points. Among the group who became newly impaired at 1 month (N=67), 7% (n=5) declined 1 point and 15% (n=10) declined 2 points.
All demographic and psychosocial characteristics examined varied by category of cognitive change (Table 1) . Fewer clinical factors varied by cognitive change status (Table 2) . For instance, although several comorbid diseases (eg, heart failure, stroke) varied by change status, with few exceptions (eg, percutaneous coronary intervention, acute renal failure), in-hospital complications and procedures did not. The risk of 6-month mortality as estimated using the GRACE risk score was higher among patients who were impaired cognitively during hospitalization mean (SD): 99 (25) in consistently impaired and 106 (31) in transiently impaired, compared with those who were not impaired: 95 (29) in consistently nonimpaired and 94 (27) in the newly impaired at 1 month. Average length of stay was longer in patients who were impaired during hospitalization, mean=4.5 days (4), irrespective of 1-month cognitive status compared with patients who were not impaired during hospitalization (mean=3.6-3.8 days; SD=3.5). Patients who were transiently impaired were more likely to be discharged to a location other than home (eg, nursing home or post-acute care setting) than were all other patients, with nearly 10% of transiently impaired patients discharged to a facility compared with 3% to 4% of all other patients.
Predictors of Change in Cognitive Status
After multivariable adjustment, several factors were associated with category of cognitive impairment change in the month after discharge, relative to patients who were consistently unimpaired (Table 3) . Men had higher odds of becoming newly impaired (OR, 2.1; 95% CI, 1.2-4.0) than women (but were no more likely than women to be transiently or consistently impaired), and participants who lived alone were more likely to be transiently impaired than those living with a spouse (OR, 1.7; 95% CI, 1.0-2.8). Lower self-reported Patients with low social support had 3× the odds of those with adequate social support to be consistently impaired (OR, 3.1; 95% CI, 1.4-6.8). Less than high school education, nonwhite race/ethnicity, and low health numeracy and literacy were associated with persistent, transient, and new impairment (Table 3) . Only 2 clinical factors were significant predictors of change category in cognitive status: history of stroke and the GRACE risk score, both of which were associated with a higher odds of being both consistently and transiently impaired, but not newly impaired at 1 month (Table 3) .
We conducted a secondary analysis restricted to those who were impaired during hospitalization and examined factors associated with transient, when compared with consistent impairment (data not shown). Patients with a college education or higher (OR, 8.3; 95% CI, 1.1, 41.6) and those who were non-Hispanic white (OR, 2.3; 95% CI, 1.3-4.5) had higher odds of transient impairment. For every point on the TICS from the in-hospital cognitive assessment, patients had 30% higher odds of transient versus consistent impairment (OR, 1.3; 95% CI, 1.1-1.4). The other patient characteristics associated with change in cognitive status in the main analyses (eg, health literacy and numeracy, history of stroke, and GRACE risk score) did not distinguish between improvement from baseline to 1 month among patients (22) 19 (29) 99 (8) Hispanic/Latino 8 (7) 8 (6) 3 (5) 26 (2) Living situation, n (%) The reanalyses of our models with inverse probability sampling to account for differential dropout yielded point estimates of model coefficients very similar to those in Table 3 , with the only changes occurring for a few variables whose P values are slightly above or slightly below the 0.05 level in each (highlighted in Table II in the Data  Supplement) . Similarly, there were no substantive changes in our findings about the relationships between patient characteristics and categories of cognitive status change after multiple imputations for missing data (data not shown).
Alternative Definition of Cognitive Change
In a sensitivity analysis, we examined an absolute change of 4 points from baseline, irrespective of impairment status at Referent group is those who are not impaired during hospitalization or at 1-mo post-discharge (n=1217). Missing data: race/ethnicity=9, perceived stress=24. ACS indicates acute coronary syndrome; GRACE, Global Registry of Acute Coronary Events; NSTEMI, non-ST-segmentelevation myocardial infarction; STEMI, ST-segment-elevation myocardial infarction; and TRACE-CORE, Transition, Risks, and Actions in Coronary Events-Center for Outcomes Research and Education. *P< 0.05. †SF-36 MCS and PCS scores are in 5-point units. ‡GRACE risk score is in 10-point units.
baseline. This change represents ≈3× that which would be expected from practice effects. 20 On the basis of this definition of cognitive change, 23% of the sample (n=347) improved in the 1 month after discharge, 8% (n=130) declined, and 67% (n=1044) remained stable. In general, findings using the alternative definition of change were similar to findings in the main analysis. Sociodemographic (eg, race and education) and psychosocial factors (eg, health literacy and numeracy, cognitive status) were associated with change in cognitive function, but few (eg, history of stroke and GRACE risk score) clinical characteristics were associated with change (Table I in 
Discussion
In one of the first studies with hospital and post-discharge measures of cognitive function in a diverse cohort of ACS survivors, we found that there is considerable change in cognitive function during the transition period from hospital to home. Over half of the patients who were impaired during hospitalization were only transiently impaired and recovered to normal cognitive function by 1 month. In addition, 5% of patients who were not impaired during hospitalization developed impairment in the month after discharge. Low health literacy, numeracy, educational attainment, and social support, as well as a history of stroke and higher GRACE risk sore, were associated with being cognitively impaired both during hospitalization and 1 month later. On the other hand, male sex, living with others, and low health literacy and numeracy were associated with the development of new cognitive impairment at 1 month.
Nearly 40% of hospitalized patients are cognitively impaired, although these rates are not specific to ACS patients. 1, 3, 30 To our knowledge, in-hospital rates of cognitive impairment have not been systematically assessed in a cohort of patients with ACS. Most studies examining cognitive function in ACS survivors only measure cognition after discharge and typically focus on long-term follow-up, 1 year or longer after the acute event. In general, these studies report that cognitive function is impaired after ACS. For example, in the TRIUMPH study (Transitional Research Investigating Underlying Disparities in Acute Myocardial Infarction Patients' Health), >50% of patients were cognitively impaired 1 month after hospital discharge. 18 The lower rates of impairment 1 month after hospital discharge observed in the current study (11%) may be because our sample was considerably younger than the subset of the TRIUMPH sample on which cognition was assessed (62 versus 73 years old). In the Health and Retirement Study, hospitalization for an acute myocardial infarction was associated with a 2.5-fold increased risk of developing mild, moderate, or severe cognitive impairment in the 1 to 3 years after discharge. 31 In several studies, cognitive change after ACS has also been compared with the impairment seen after stroke. One study found that ACS survivors were more than twice as likely than survivors of transient ischemic attacks to have moderate or severe cognitive impairment 1 year after the acute event. 32 In the Health and Retirement Study, cognitive decline accelerated in the years after stroke but not myocardial infarction, 33 suggesting that cognitive change in the transition from hospital to home may be important in understanding long-term trajectories of decline.
Sixteen percent of our cohort were impaired during hospitalization, and 11% were impaired 1 month after discharge, but there was considerable change with remediation of cognitive function in patients who were impaired during hospitalization and development of new impairment. Also of note, we excluded demented, delirious, and palliative care patients from our study, suggesting that our sample was relatively high functioning relative to all patients hospitalized annually in the United States for ACS.
Our results highlight the importance of serial assessments of cognitive function during transition periods. With the aging of the US population and improvement in survival after hospitalization for ACS, clinicians and patients are increasingly concerned with factors associated with quality of life, including cognitive status, as important outcomes of an acute event. 34 Previous literature has focused on single assessments of cognitive function, either during hospitalization or after discharge, but few have measured cognitive function at multiple time points and thus we lack an understanding of how cognitive performance changes during the transitional period from hospital to home. Temporary cognitive impairment, particularly if not associated with an acute delirium, may signal a patient at risk for poor outcomes. For instance, in a study of all elderly patients on a general medicine service, cognitive impairment during hospitalization that resolved by discharge was associated with a 2-fold increased risk of death in the year after discharge. 10 Cognitive impairment around the time of hospital discharge has been described as both a predictor and consequence of the proposed Post-Hospital Syndrome. 9 As such, cognitive ability may influence ability to comprehend and follow discharge instructions, to carry out disease self-management and to fully recover physical function after hospitalization. We found both improvement and decline in cognitive function after discharge for ACS, underscoring the importance of serial cognitive testing. Important questions remain including whether patients with the various cognitive trajectories we identified (eg, transiently impaired, consistently impaired) have different rates of long-term clinical outcomes. For instance, transient impairment may represent an intermediary risk category between nonimpaired and consistently impaired with respect to functional recovery, rehospitalization, or effective disease self-management.
Our findings are strengthened by the diversity of the sample and comprehensive assessment of the demographic, psychosocial, and clinical characteristics of the cohort. We had serial assessments of cognitive function, both in and out of the hospital, and we examined alternative definitions of change, including those linked to a cut point and absolute change, with similar overall results.
Several limitations of this study should be noted. The sample with baseline and 1-month data was predominately nonHispanic white (84%) and slightly underrepresented women (67% male). We had attrition from baseline to 1-month follow-up, and those who did not complete 1-month interviews had significantly poorer cognitive function at baseline, and also higher psychosocial vulnerability; thus, the observed associations are likely to be stronger without this attrition. We excluded patients who were delirious or demented at the time Change in Cognitive Function After Hospitalization of enrollment, resulting in a higher functioning cohort that likely underestimates the prevalence of cognitive impairment during hospitalization. Although we screened for delirium, it is possible that we enrolled patients with subsyndromal delirium or those who developed delirium after our study interview. Similarly, because dementia is underdiagnosed in the medical record, 35 it is possible that we enrolled patients who were demented but did not have the diagnosis in their record. Unrecognized delirious or demented patients would be more likely to be cognitively impaired and to have poorer cognitive function after discharge. Like all cognitive screening tests, the TICS may be biased by education. In addition, we administered the TICS twice in a 1-month period, which could have resulted in some increase in scores because of practice effects because alternate forms of the TICS do not exist. However, in sensitivity analyses, we examined change in cognition that was ≈3× that which would be expected from practice effects and found similar results to our main model. Similarly, use of cut points, although conventional in cognitive impairment assessment, inevitably resulted in some participants with small absolute changes in TICS score moving between nonimpaired and impaired. However, the proportions of those who would have been reclassified if we had precluded a 1-point change from resulting in reclassification were small (3% for the transiently impaired and 7% for the newly impaired). The mode of administration of the TICS changed between the baseline (in-person) and follow-up (via telephone) assessments. Although the change in mode of administration may have resulted in a slight difference in test performance between the baseline and follow-up examination, it is unlikely to have impacted group membership (eg, being in the consistently impaired versus in the transiently impaired group) because the average change was 6 points (3 SDs) in the transiently impaired group and 4 points (2 SDs) in the newly impaired group. Health literacy and numeracy were assessed using brief (1 and 2 items, respectively) screening instruments, and future work should include more expanded assessments with greater validity and reliability. We did not have information on timing of in-hospital treatments or procedures relative to the timing of the cognitive assessments therefore cannot examine whether procedures impacted baseline cognitive performance.
Conclusions
In this diverse cohort of ACS survivors, we found considerable change, both improvement and decline, in cognitive function during the high-risk transitional period from hospital to home. We also found that markers of psychosocial vulnerability (eg, low health literacy and numeracy, poor social support) are generally associated with cognitive impairment and lower likelihood of recovery. Thus, assessing cognition both in hospital and post-discharge is important for detecting patients who could benefit from tailored transitional care, including early follow-up appointments with healthcare providers, increased surveillance, and booster post-discharge instructions.
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